We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $303B
1-Year Est. Return 53.02%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+53.02%
3 Year Est. Return
+141.18%
5 Year Est. Return
+166.47%
10 Year Est. Return
+608.47%
AUM
$187B
AUM Growth
+$17.4B
Cap. Flow
+$6.91B
Cap. Flow %
3.7%
Top 10 Hldgs %
24.65%
Holding
6,293
New
489
Increased
2,934
Reduced
1,746
Closed
426

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$1.01B
2
MSFT icon
Microsoft
MSFT
+$727M
3
AMZN icon
Amazon
AMZN
+$478M
4
PYPL icon
PayPal
PYPL
+$450M
5
AAPL icon
Apple
AAPL
+$448M

Sector Composition

Rank Sector Weight
1 Technology 13.35%
2 Financials 6.13%
3 Consumer Discretionary 6.04%
4 Healthcare 5.03%
5 Communication Services 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAK icon
1751
CALL
Takeda Pharmaceutical
TAK
$54.6B
$5.45M ﹤0.01%
400,000
ICPT
1752
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5.45M ﹤0.01%
334,691
+115,538
+53% +$1.95M
MLCO icon
1753
Melco Resorts & Entertainment
MLCO
$2.22B
$5.45M ﹤0.01%
535,104
+151,318
+39% +$1.61M
EXEL icon
1754
Exelixis
EXEL
$13.3B
$5.43M ﹤0.01%
296,919
+137,655
+86% +$2.63M
TPTX
1755
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$5.41M ﹤0.01%
113,403
+78,514
+225% +$3.51M
AQN icon
1756
Algonquin Power & Utilities
AQN
$4.49B
$5.4M ﹤0.01%
373,499
-37,170
-9% -$532K
JBLU icon
1757
JetBlue
JBLU
$2.28B
$5.4M ﹤0.01%
379,184
-23,929
-6% -$352K
BCRX icon
1758
BioCryst Pharmaceuticals
BCRX
$2.28B
$5.39M ﹤0.01%
388,878
+226,689
+140% +$3M
VCYT icon
1759
Veracyte
VCYT
$3.7B
$5.38M ﹤0.01%
130,604
+56,607
+76% +$2.5M
DXCM icon
1760
PUT
DexCom
DXCM
$31.5B
$5.37M ﹤0.01%
+40,000
New +$5.75M
DNLI icon
1761
Denali Therapeutics
DNLI
$3.65B
$5.37M ﹤0.01%
120,381
+11,356
+10% +$538K
ROBO icon
1762
ROBO Global Robotics & Automation Index ETF
ROBO
$2.02B
$5.37M ﹤0.01%
76,561
-8,397
-10% -$574K
BPOP icon
1763
Popular Inc
BPOP
$11.2B
$5.36M ﹤0.01%
65,317
-4,085
-6% -$331K
TM icon
1764
Toyota
TM
$224B
$5.34M ﹤0.01%
28,840
-797
-3% -$143K
ST icon
1765
Sensata Technologies
ST
$6.74B
$5.33M ﹤0.01%
86,345
+6,771
+9% +$394K
MOG.A icon
1766
Moog Inc Class A
MOG.A
$12.4B
$5.33M ﹤0.01%
65,764
+10,486
+19% +$813K
ABG icon
1767
Asbury Automotive
ABG
$4.31B
$5.31M ﹤0.01%
30,751
+2,857
+10% +$526K
FWONK icon
1768
Liberty Media Series C
FWONK
$24.6B
$5.31M ﹤0.01%
86,765
+5,746
+7% +$323K
BIP icon
1769
Brookfield Infrastructure Partners
BIP
$19.2B
$5.3M ﹤0.01%
130,853
+68,918
+111% +$2.66M
PTCT icon
1770
PTC Therapeutics
PTCT
$5.68B
$5.29M ﹤0.01%
132,868
+57,012
+75% +$2.18M
ABCL icon
1771
CALL
AbCellera Biologics
ABCL
$1.74B
$5.29M ﹤0.01%
370,000
-143,700
-28% -$2.18M
CDNA icon
1772
CareDx
CDNA
$2.26B
$5.29M ﹤0.01%
116,296
+67,057
+136% +$3.5M
IVR icon
1773
Invesco Mortgage Capital
IVR
$759M
$5.29M ﹤0.01%
190,236
+40,862
+27% +$1.27M
PSN icon
1774
Parsons
PSN
$4.72B
$5.28M ﹤0.01%
156,994
-9,071
-5% -$315K
LNW
1775
DELISTED
Light & Wonder
LNW
$5.28M ﹤0.01%
78,981
-92,879
-54% -$6.76M

Similar funds

Citigroup's Q4 2021 Portfolio in Review

As of Q4 2021, Citigroup held 6,293 positions worth $187B, up 10% from $169B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Citigroup deployed $6.91B of net new capital in Q4 2021, opening 489 new positions and adding to 2,934 existing holdings. Its largest new stake was Nu Holdings: 27,608,577 shares worth $259M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $800M trimmed.

  • Citigroup's largest Q4 2021 buy was Nu Holdings: 27,608,577 shares worth $259M.
  • Citigroup added most to Carvana in Q4 2021, an estimated $1.01B increase.
  • Citigroup's biggest Q4 2021 reduction was Invesco QQQ Trust, cutting an estimated $800M.
  • Citigroup fully exited ProShares UltraPro Short QQQ in Q4 2021, selling an estimated $149M.
  • Citigroup's ten largest holdings make up 25% of its $187B portfolio in Q4 2021.
  • Citigroup opened 489 new positions and closed 426 in Q4 2021.
  • Citigroup's portfolio value rose 10% quarter-over-quarter to $187B.

Based on Citigroup's 13F filing for Q4 2021, filed 10 Feb 2022.